preview

The Flawed Food And Drug Administration

Good Essays

Tristan Bennett Ms. Romine ENG 1010 4 December 2015 The Flawed Food and Drug Administration The Food and Drug Administration dates back to the late 1840s, though it did not adopt that name until 1930. The first act if the FDA as it is known today was officially established in 1906 with the passage of its first piece of legislature. was the passage of the 1906 pure food and drug act, which prohibited the interstate commerce of misbranded food and drugs, and thus establish the FDA . It was established by the government, and thus inherited sits bureaucratic structure. ome of its flaws . Furthermore , the FDA was established as a council to regulate agricultural products through chemical analysis, and thus its structure is incredibly flawed …show more content…

AThe major new capability from the previous members of the animus pump family,of the Animas vibe is the continuous glucose monitor CGM integration. A CGM is a wearable device that measures glucose levels in body fluids. It is’s able to give trends, and alert young and old users a like to take action when their sugar is low or high. Before the Vibe was introduced, users would carry two separate devices which each had separate suite of software to sync with a computer and share with their health care provider. This made diabetes management difficult, and added another device to the large arsenal of things that tools that one diabetics must depend on a daily basis. The integration of the CGM and insulin pump was revolutionary, yet because it was not approved by the FDA, users were left with only inconvenient, outdated equipment . The integration of the Dexcom CGM and the Animas insulin pump was approved by the CE mark on June 2, 2011. The CE mark is the European approval for medical devices and other products. It was also approved by health Canada, the Canadian equivalency of the FDA on September 18 of 2013. According to the Animas homepage, “On November 25, 2014, Animas® Vibe™ was approved by the FDA for the management of insulin-requiring diabetes in adult patients ages 18 and older,” while being approved for patients under the age of 18 in the UK, as of March 6 of 2014. This slow and

Get Access